The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013
Open accessAbstract
Importance: It is important to understand the magnitude and distribution of the economic burden of prescription opioid overdose, abuse, and dependence to inform clinical practice, research, and other decision makers. Decision makers choosing approaches to address this epidemic need cost information to evaluate the cost effectiveness of their choices. Objective: To estimate the economic burden of prescription opioid overdose, abuse, and dependence from a societal perspective. Design, Setting, and Participants: Incidence of fatal prescription opioid overdose from the National Vital Statistics System, prevalence of abuse and dependence from the National Survey of Drug Use and Health. Fatal data are for the US population, nonfatal data are a nationally representative sample of the US civilian noninstitutionalized population ages 12 and older. Cost data are from various sources including health care claims data from the Truven Health MarketScan Research Databases, and cost of fatal cases from the WISQARS (Web-based Injury Statistics Query and Reporting System) cost module. Criminal justice costs were derived from the Justice Expenditure and Employment Extracts published by the Department of Justice. Estimates of lost productivity were based on a previously published study. Exposure: Calendar year 2013. Main Outcomes and Measures: Monetized burden of fatal overdose and abuse and dependence of prescription opioids. Results: The total economic burden is estimated to be $78.5 billion. Over one third of this amount is due to increased health care and substance abuse treatment costs ($28.9 billion). Approximately one quarter of the cost is borne by the public sector in health care, substance abuse treatment, and criminal justice costs. Conclusions and Relevance: These estimates can assist decision makers in understanding the magnitude of adverse health outcomes associated with prescription opioid use such as overdose, abuse, and dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“many of these domains are featured in existing studies of the economic burden of SUDs”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“This is a change from previously published estimates, where a large share of costs was attributable to opioid use disorder (Birnbaum et al., 2011; Florence et al., 2016; Rice et al., 2014).”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Matching controlled for basic demographic variables, health status was matched based on the Charlson comorbidity index and health care costs prior to use disorder diagnosis, and regression models controlled for skewness in the expenditure data.”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The original source study used a matched case-control design to estimate the impact of opioid use disorder diagnoses on health care spending.”
From The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017 (2021) · cites this paper as Florence et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350
Pharmaceutical Overdose Deaths, United States, 2010
Jones, C. M., Mack, K. A., & Paulozzi, L. J. (2013) · JAMA · doi:10.1001/jama.2013.272 · Cited by 678
Societal costs of prescription opioid abuse, dependence, and misuse in the United States
Birnbaum, H. G., White, A. G., Schiller, M., Waldman, T., Cleveland, J. M., & Roland, C. L. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01075.x · Cited by 644
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
(2011) · PubMed · Cited by 640
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 502
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 494
Economic Costs of Nonmedical Use of Prescription Opioids
Hansen, R. N., Oster, G., Edelsberg, J., WOODY, G. E., & Sullivan, S. D. (2010) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181ff04ca · Cited by 183
Economic Burden of Prescription Opioid Misuse and Abuse
Strassels, S. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.7.556 · Cited by 148
Estimated Costs of Prescription Opioid Analgesic Abuse in the United States in 2001
Birnbaum, H. G., White, A. G., Reynolds, J. L., Greenberg, P. E., Zhang, M., Vallow, S., Schein, J. R., & Katz, N. P. (2006) · Clinical Journal of Pain · doi:10.1097/01.ajp.0000210915.80417.cf · Cited by 139
Ballesteros, M. F., Webb, K. B., & McClure, R. (2017) · Journal of Safety Research · doi:10.1016/j.jsr.2017.01.001 · Cited by 126
Cited by
Sorted by citations
Ferreira, M. L., de Luca, K. E., Haile, L. M., Steinmetz, J. D., Culbreth, G. T., Cross, M., Kopec, J. A., Ferreira, P. H., Blyth, F., Buchbinder, R., et al. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00098-x · Cited by 2,122
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Vital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117
Nelson, G., Bakkum-Gamez, J., Kalogera, E., Glaser, G., Altman, A., Meyer, L., Taylor, J. S., Iniesta, M., Lasala, J., Mena, G., et al. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000356 · Cited by 678
Hah, J. M., Bateman, B. T., Ratliff, J., Curtin, C., & Sun, E. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002458 · Cited by 728
The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017
Florence, C., Luo, F., & Rice, K. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108350 · Cited by 511
Self-citationThe ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
(2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000633 · Cited by 412
Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care
Tick, H., Nielsen, A., Pelletier, K. R., Bonakdar, R. A., Simmons, S., Glick, R. M., Ratner, E. F., Lemmon, R., Wayne, P. M., & Zador, V. (2018) · EXPLORE · doi:10.1016/j.explore.2018.02.001 · Cited by 404
Wide Variation and Overprescription of Opioids After Elective Surgery
Thiels, C. A., Anderson, S. S., Ubl, D. S., Hanson, K. T., Bergquist, W. J., Gray, R. J., Gazelka, H. M., Cima, R. R., & Habermann, E. B. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002365 · Cited by 349
New Data on Opioid Use and Prescribing in the United States
Schuchat, A., Houry, D., & Guy, G. P. (2017) · JAMA · doi:10.1001/jama.2017.8913 · Cited by 334
Smart, R., & Pacula, R. L. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669626 · Cited by 305
Rate and Risk Factors Associated With Prolonged Opioid Use After Surgery
Lawal, O. D., Gold, J. L., Murthy, A., Ruchi, R., Bavry, E., Hume, A. L., Lewkowitz, A. K., Brothers, T. N., & Wen, X. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.7367 · Cited by 301
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
Chen, Q., Larochelle, M. R., Weaver, D. T., Lietz, A. P., Mueller, P. P., Mercaldo, S., Wakeman, S. E., Freedberg, K. A., Raphel, T. J., Knudsen, A. B., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7621 · Cited by 273
Perioperative Opioid Administration
Shanthanna, H., Ladha, K. S., Kehlet, H., & Joshi, G. P. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003572 · Cited by 268
Witkiewitz, K., & Vowles, K. E. (2018) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13594 · Cited by 248
Multimorbidity Trends in United States Adults, 1988–2014
King, D. E., Xiang, J. Y., & Pilkerton, C. S. (2018) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2018.04.180008 · Cited by 248
Immersive Virtual Reality and Virtual Embodiment for Pain Relief
Matamala-Gomez, M., Donegan, T., Bottiroli, S., Sandrini, G., Sanchez-Vives, M. V., & Tassorelli, C. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00279 · Cited by 262
Continuous Opioid Monitoring along with Nerve Agents on a Wearable Microneedle Sensor Array
Mishra, R. K., Goud, K. Y., Li, Z., Moonla, C., Mohamed, M. A., Tehrani, F., Teymourian, H., & Wang, J. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c01883 · Cited by 239
Lo-Ciganic, W.-H., Huang, J. L., Zhang, H. H., Weiss, J. C., Wu, Y., Kwoh, C. K., Donohue, J. M., Cochran, G., Gordon, A. J., Malone, D. C., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0968 · Cited by 228
Patterns of Opioid Prescription and Use After Cesarean Delivery
Bateman, B. T., Cole, N. M., Maeda, A., Burns, S. M., Houle, T. T., Huybrechts, K. F., Clancy, C. R., Hopp, S., Ecker, J. L., Ende, H. B., et al. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002093 · Cited by 228
Defining Optimal Length of Opioid Pain Medication Prescription After Common Surgical Procedures
Scully, R. E., Schoenfeld, A. J., Jiang, W., Lipsitz, S., Chaudhary, M. A., Learn, P. A., Koehlmoos, T., Haider, A. H., & Nguyen, L. L. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2017.3132 · Cited by 215
Toll-like receptors and their role in persistent pain
Lacagnina, M. J., Watkins, L. R., & Grace, P. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.006 · Cited by 216
Pathan, S. A., Mitra, B., & Cameron, P. A. (2017) · European Urology · doi:10.1016/j.eururo.2017.11.001 · Cited by 193
Emergency department screening and interventions for substance use disorders
Hawk, K. F., & D’Onofrio, G. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0117-1 · Cited by 194
How good intentions contributed to bad outcomes: the opioid crisis
Rummans, T. A., Burton, M. C., & Dawson, N. L. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.12.020 · Cited by 174
Park, J. N., Rouhani, S., Beletsky, L. A., VINCENT, L., Saloner, B. K., & Sherman, S. G. (2020) · Milbank Quarterly · doi:10.1111/1468-0009.12470 · Cited by 165
Cost-effectiveness of Treatments for Opioid Use Disorder
Fairley, M., Humphreys, K. N., Joyce, V. R., Bounthavong, M., Trafton, J. A., Combs, A., Oliva, E. M., Goldhaber‐Fiebert, J. D., Asch, S. M., Brandeau, M. L., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0247 · Cited by 163
A Review of the Opioid Epidemic: What Do We Do About It?
Shipton, E. A., Shipton, A. J., & Shipton, A. J. (2018) · Pain and Therapy · doi:10.1007/s40122-018-0096-7 · Cited by 167
Grim, B. J., & Grim, M. E. (2019) · Journal of Religion and Health · doi:10.1007/s10943-019-00876-w · Cited by 157
The macroeconomic burden of noncommunicable diseases in the United States: Estimates and projections
Chen, S., Kühn, M., Klaus Prettner, A., & Bloom, D. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206702 · Cited by 156
Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse
Grecu, A. C., Dave, D., & Saffer, H. (2018) · Journal of Policy Analysis and Management · doi:10.1002/pam.22098 · Cited by 154
Dezfulian, C., Orkin, A. M., Maron, B. A., Elmer, J., Girotra, S. R., Gladwin, M. T., Merchant, R. M., Panchal, A. R., Perman, S. M., Starks, M. A., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000958 · Cited by 151
Opioids After Surgery in the United States Versus the Rest of the World
Kaafarani, H. M. A., Han, K. R., Moheb, M. N. E., Kongkaewpaisan, N., Jia, Z., Hechi, M. W. E., Wijck, S. F. M. V., Breen, K., Eid, A., Rodriguez, G., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004225 · Cited by 150
Helmerhorst, G. T. T., Teunis, T., Janssen, S. J., & Ring, D. (2017) · The Bone & Joint Journal · doi:10.1302/0301-620x.99b7.bjj-2016-1350.r1 · Cited by 141
Integration of personalized drug delivery systems into digital health
Raijada, D. K., Wac, K., Greisen, E., Rantanen, J., & Genina, N. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113857 · Cited by 142
Skees, A. J., Foppe, K. S., Loganathan, B. G., & Subedi, B. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.03.060 · Cited by 136
Sustained Preoperative Opioid Use Is a Predictor of Continued Use Following Spine Surgery
Schoenfeld, A. J., Belmont, P. J., Blucher, J. A., Jiang, W., Chaudhary, M. A., Koehlmoos, T. P., Kang, J. D., & Haider, A. H. (2018) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.17.00862 · Cited by 128
Karhade, A. V., Ogink, P. T., Thio, Q. C. B. S., Broekman, M. L. D., Cha, T. D., Hershman, S. H., Mao, J., Peul, W. C., Schoenfeld, A. J., Bono, C. M., et al. (2019) · The Spine Journal · doi:10.1016/j.spinee.2019.01.009 · Cited by 127
Jain, N., Brock, J. L., Malik, A. T., Phillips, F. M., & Khan, S. N. (2019) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.18.00502 · Cited by 126
Stein, B. D., Dick, A. W., Sorbero, M., Gordon, A. J., Burns, R. M., LESLIE, D. L., & Pacula, R. L. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1449166 · Cited by 131
Expanding access to buprenorphine treatment in rural areas with the use of telemedicine
Weintraub, E., Greenblatt, A. D., Chang, J. W., Himelhoch, S. S., & Welsh, C. (2018) · American Journal on Addictions · doi:10.1111/ajad.12805 · Cited by 124
The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse
Soffin, E. M., Lee, B. H., Kumar, K. K., & Wu, C. L. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.11.019 · Cited by 127
The Initiation of Chronic Opioids: A Survey of Chronic Pain Patients
Callinan, C. E., Neuman, M. D., Lacy, K. E., Gabison, C., & Ashburn, M. A. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.11.001 · Cited by 114
Harnessing the Chemistry of the Indole Heterocycle to Drive Discoveries in Biology and Medicine
Norwood, V. M., & Huigens, R. W. (2019) · ChemBioChem · doi:10.1002/cbic.201800768 · Cited by 112
Jain, N. K., Brock, J. L., Phillips, F. M., Weaver, T. E., & Khan, S. N. (2018) · The Spine Journal · doi:10.1016/j.spinee.2018.03.015 · Cited by 108
Risk Factors and Pooled Rate of Prolonged Opioid Use Following Trauma or Surgery
Mohamadi, A., Chan, J. J., Lian, J., Wright, C. L., Marin, A. M., Rodriguez, E. K., Keudell, A. G. V., & Nazarian, A. (2018) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.17.01239 · Cited by 108
Ronquest, N. A., Willson, T. M., Montejano, L. B., Nadipelli, V. R., & Wollschlaeger, B. (2018) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s150253 · Cited by 107
A bioresorbable peripheral nerve stimulator for electronic pain block
Lee, G., Ray, E., Yoon, H., Genovese, S., Choi, Y. S., Lee, M., Şahin, S., Yan, Y., Ahn, H., Bandodkar, A. J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp9169 · Cited by 109
Hulme, S., Bright, D. A., & Nielsen, S. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.02.010 · Cited by 104
Cook, D. J., Kaskovich, S., Pirkle, S., Mica, M. C., Shi, L. L., & Lee, M. J. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.12.023 · Cited by 101
Buprenorphine in the United States: Motives for abuse, misuse, and diversion
Chilcoat, H. D., Amick, H. R., Sherwood, M. R., & Dunn, K. E. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.07.005 · Cited by 100
Barr, P. B., Bigdeli, T. B., & Meyers, J. L. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.0685 · Cited by 101
Lenfant, L., Sawczyn, G., Aminsharifi, A., Kim, S., Wilson, C. A., Beksac, A. T., Schwen, Z. R., & Kaouk, J. H. (2020) · European Urology Focus · doi:10.1016/j.euf.2020.10.006 · Cited by 94
Hasan, N., Imran, M., Kesharwani, P., Khanna, K., Karwasra, R., Sharma, N., Rawat, S., Sharma, D., Ahmad, F. J., Jain, G. K., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120428 · Cited by 94
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations
Anne, S., Mims, J. “., Tunkel, D. E., Rosenfeld, R. M., Boisoneau, D. S., Brenner, M. J., Cramer, J. D., Dickerson, D. M., Finestone, S. A., Folbe, A. J., et al. (2021) · Otolaryngology · doi:10.1177/0194599821996297 · Cited by 94
Building recovery ready communities: the recovery ready ecosystem model and community framework
Ashford, R. D., Brown, A. M., Ryding, R., & Curtis, B. L. (2019) · Addiction Research & Theory · doi:10.1080/16066359.2019.1571191 · Cited by 99
Zhang, Y., Kahng, M. W., Elkind, J. A., Weir, V. R., Hernandez, N. S., Stein, L. M., & Schmidt, H. D. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0531-4 · Cited by 92
Mackey, T. K., Kalyanam, J., Klugman, J., Kuzmenko, E., & Gupta, R. (2018) · Journal of Medical Internet Research · doi:10.2196/10029 · Cited by 100
Predicting opioid dependence from electronic health records with machine learning
Ellis, R. J., Wang, Z., Genes, N. G., & Ma’ayan, A. (2019) · BioData Mining · doi:10.1186/s13040-019-0193-0 · Cited by 95
Trends in Medical Use of Opioids in the U.S., 2006–2016
Piper, B. J., Shah, D. T., Simoyan, O. M., McCall, K. L., & Nichols, S. D. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.01.034 · Cited by 91
Blevins, M. L., Weeks, H. L., Pisansky, A. J. B., Yong, R., & Stringer, E. A. (2019) · Pain Medicine · doi:10.1093/pm/pnz083 · Cited by 88
Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics
Grim, T. W., Acevedo‐Canabal, A., & Bohn, L. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.10.020 · Cited by 89
Economic Studies on the Opioid Crisis: A Review
Maclean, J. C., Mallatt, J., Ruhm, C. J., & Simon, K. I. (2020) · National Bureau of Economic Research · doi:10.3386/w28067 · Cited by 86
Association of opioid misuse with anxiety and depression: A systematic review of the literature
Rogers, A. H., Zvolensky, M. J., Ditre, J. W., Buckner, J. D., & Asmundson, G. J. G. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.101978 · Cited by 93
Opioid prescribing practices from 2010 through 2015 among dentists in the United States
Gupta, N., Vujicic, M., & Blatz, A. (2018) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2018.01.005 · Cited by 86
Hasler, W. L., Wilson, L., Nguyen, L. A. B., Snape, W. J., Abell, T. L., Koch, K. L., McCallum, R. W., Pasricha, P. J., Sarosiek, I., Farrugia, G., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.013 · Cited by 83
Perioperative Management of Buprenorphine: Solving the Conundrum
Quaye, A., & Zhang, Y. (2018) · Pain Medicine · doi:10.1093/pm/pny217 · Cited by 83
Zhao-Fleming, H. H., Hand, A., Zhang, K., Polák, R., Northcut, A., Jacob, D., Dissanaike, S., & Rumbaugh, K. P. (2018) · Burns & Trauma · doi:10.1186/s41038-018-0128-x · Cited by 85
Prescribing patterns of buprenorphine waivered physicians
Parks, C. L., Doyle, E., Kreiner, P. W., Jones, C. M., Dubenitz, J., Horan, A., & Stein, B. D. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.002 · Cited by 80
The affordable care act transformation of substance use disorder treatment
Abraham, A. J., Andrews, C. M., Grogan, C. M., D’Aunno, T., Humphreys, K. N., Pollack, H. A., & Friedmann, P. D. (2017) · American Journal of Public Health · doi:10.2105/ajph.2016.303558 · Cited by 79
Bunting, A. M., Oser, C. B., Staton, M., Eddens, K. S., & Knudsen, H. K. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0124-2 · Cited by 84
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
Abraham, A. J., Andrews, C. M., Harris, S. J., & Friedmann, P. D. (2020) · Neurotherapeutics · doi:10.1007/s13311-019-00814-4 · Cited by 79
Purtle, J., Lê‐Scherban, F., Wang, X., Shattuck, P. T., Proctor, E. K., & Brownson, R. C. (2018) · Implementation Science · doi:10.1186/s13012-018-0816-8 · Cited by 78
Ma, L., Chen, R., Ge, W., Rogers, P., Lyn-Cook, B., Hong, H., Tong, W.-D., Wu, N.-N., & Zou, W. (2025) · Experimental biology and medicine · doi:10.3389/ebm.2025.10389 · Cited by 65
Prevalence and charges of opioid-related visits to U.S. emergency departments
Langabeer, J. R., Stotts, A. L., Bobrow, B. J., Wang, H. E., Chambers, K. A., Yatsco, A. J., Cárdenas-Turanzas, M., & Champagne‐Langabeer, T. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108568 · Cited by 76
Chronic Opioid Use Following Surgery for Oral Cavity Cancer
Pang, J., Tringale, K. R., Tapia, V. J., Moss, W. J., May, M. E., Furnish, T. J., Barnachea, L., Brumund, K. T., Sacco, A. G., Weisman, R. A., et al. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2017.0582 · Cited by 77
Rao, I. J., Humphreys, K. N., & Brandeau, M. L. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100031 · Cited by 75
Cuesta, S., Burdisso, P., Segev, A., Kourrich, S., & Sperandio, V. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.09.014 · Cited by 76
Epidemiology from Tweets: Estimating Misuse of Prescription Opioids in the USA from Social Media
Chary, M. A., Genes, N. G., Giraud-Carrier, C. G., Hanson, C. L., Nelson, L. S., & Manini, A. F. (2017) · Journal of Medical Toxicology · doi:10.1007/s13181-017-0625-5 · Cited by 75
Glasscott, M. W., Vannoy, K. J., Fernando, P. U. A. I., Kosgei, G. K., Moores, L. C., & Dick, J. E. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116037 · Cited by 74
Autoimmune regulation of chronic pain
Lacagnina, M. J., Heijnen, C. J., Watkins, L. R., & Grace, P. M. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000905 · Cited by 76
Sex differences in oral oxycodone self‐administration and stress‐primed reinstatement in rats
Fulenwider, H. D., Nennig, S. E., Hafeez, H., Price, M. E., Baruffaldi, F., Pravetoni, M., Cheng, K., Rice, K. C., Manvich, D. F., & Schank, J. R. (2019) · Addiction Biology · doi:10.1111/adb.12822 · Cited by 71
Chang, R. W., Tompkins, D. M., & Cohn, S. M. (2020) · The American Surgeon · doi:10.1177/0003134820952834 · Cited by 74
Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond
Gaddis, N., Mathur, R., Marks, J. A., Zhou, L., Quach, B. C., Waldrop, A., Levran, O., Arpana Agrawal, A., Randesi, M., Adelson, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21003-y · Cited by 75
Short‐ and Long‐term Opioid Use in Patients with Oral and Oropharynx Cancer
McDermott, J. D., Eguchi, M., Stokes, W. A., Amini, A., Hararah, M. K., Ding, D., Valentine, A., Bradley, C. J., & Karam, S. D. (2018) · Otolaryngology · doi:10.1177/0194599818808513 · Cited by 71
Wright, C. D., Tiani, A. G., Billingsley, A. L., Steinman, S. A., Larkin, K. T., & McNeil, D. W. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.02498 · Cited by 76
Burden of cancer pain in developing countries: a narrative literature review
Li, Z., Aninditha, T., Griene, B., Javier, F., Renato, P., Serrié, A., Umareddy, I., Boisseau, S., & Hadjiat, Y. (2018) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s181192 · Cited by 70
Opioid Use and Intimate Partner Violence: a Systematic Review
Stone, R., & Rothman, E. F. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-00197-2 · Cited by 71
Kurani, S. S., Grubina, R., Inselman, J., Jeffery, M. M., Chawla, S. S., Rutten, L. J. F., Giblon, R. E., & Shah, N. D. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035376 · Cited by 69
The cost of opioid use disorder and the value of aversion
Murphy, S. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108382 · Cited by 69
The Role of Technology-Based Interventions for Substance Use Disorders in Primary Care
Tofighi, B., Abrantes, A. M., & Stein, M. D. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.011 · Cited by 69
What do we know about opportunities and challenges for localities from Cannabis legalization?
Kavousi, P., Giamo, T., Arnold, G., Alliende, M., Huynh, E. K., Lea, J., Lucine, R., Miller, A. T., Webre, A., Yee, A., et al. (2021) · Review of Policy Research · doi:10.1111/ropr.12460 · Cited by 67
State prescription drug monitoring programs and fatal drug overdoses.
Nam, Y. H., Shea, D. G., Shi, Y., & Moran, J. R. (2017) · PubMed · Cited by 66
Binge Drinking and Prescription Opioid Misuse in the U.S., 2012–2014
Esser, M. B., Guy, G. P., Zhang, K., & Brewer, R. D. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.02.025 · Cited by 69
Access to Health Care and Criminal Behavior: Short-Run Evidence from the ACA Medicaid Expansions
Vogler, J. (2017) · Journal of Policy Analysis and Management · doi:10.1002/pam.22239 · Cited by 71
Taylor, B. G., Lamuda, P. A., Flanagan, E. A., Watts, E. A., Pollack, H. A., & Schneider, J. A. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1949611 · Cited by 65
Reinhart, M. L., Scarpati, L. M., Kirson, N. Y., Patton, C., Shak, N., & Erensen, J. G. (2018) · Applied Health Economics and Health Policy · doi:10.1007/s40258-018-0402-x · Cited by 65
Persistent Opioid Use Among Children, Adolescents, and Young Adults After Common Cleft Operations
Bennett, K. G., Harbaugh, C. M., Hu, H. M., Vercler, C. J., Buchman, S. R., Brummett, C. M., & Waljee, J. F. (2018) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000004762 · Cited by 63
The Cambridge Handbook of Substance and Behavioral Addictions
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591 · Cited by 64
Opioid Prescription Rates And Child Removals: Evidence From Florida
Quast, T. C., Storch, E. A., & Yampolskaya, S. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1023 · Cited by 65
Metadata
- Authors
- Florence, C. S., Zhou, C., Luo, F., & Xu, L.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Medical Care
- Published
- 2016-10
- Volume
- 54
- Issue
- 10
- Pages
- 901-906
- ISSN
- 0025-7079 (ISSN-L)
- PMC
- PMC5975355
- OpenAlex
- W2519105412
- Cited by
- 1,152
- References
- 15
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 51 · 2023: 79 · 2022: 125 · 2021: 195 · 2020: 265 · 2019: 185 · 2018: 128 · 2017: 45 · 2016: 5
- FWCI
- 119.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Medical Care (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- prescription opioid overdose, opioid abuse, opioid use disorder, economic burden, social costs, health care costs, criminal justice costs, productivity loss, fatal overdose, opioid epidemic
- MeSH terms
- Absenteeism, Prescription Drug Overuse, Criminal Law, Female, Humans, Male, Opioid-Related Disorders, United States, Health Care Costs, Cost of Illness, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review